These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17823868)

  • 1. Treatment eligibility and outcomes in elderly patients with chronic hepatitis C: results from the VA HCV-001 Study.
    Tsui JI; Currie S; Shen H; Bini EJ; Brau N; Wright TL;
    Dig Dis Sci; 2008 Mar; 53(3):809-14. PubMed ID: 17823868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.
    Bini EJ; Bräu N; Currie S; Shen H; Anand BS; Hu KQ; Jeffers L; Ho SB; Johnson D; Schmidt WN; King P; Cheung R; Morgan TR; Awad J; Pedrosa M; Chang KM; Aytaman A; Simon F; Hagedorn C; Moseley R; Ahmad J; Mendenhall C; Waters B; Strader D; Sasaki AW; Rossi S; Wright TL
    Am J Gastroenterol; 2005 Aug; 100(8):1772-9. PubMed ID: 16086714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telemedicine Specialty Support Promotes Hepatitis C Treatment by Primary Care Providers in the Department of Veterans Affairs.
    Beste LA; Glorioso TJ; Ho PM; Au DH; Kirsh SR; Todd-Stenberg J; Chang MF; Dominitz JA; Barón AE; Ross D
    Am J Med; 2017 Apr; 130(4):432-438.e3. PubMed ID: 27998682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early virologic responses and hematologic safety of direct-acting antiviral therapies in veterans with chronic hepatitis C.
    Belperio PS; Hwang EW; Thomas IC; Mole LA; Cheung RC; Backus LI
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1021-7. PubMed ID: 23524130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C.
    Honda T; Katano Y; Shimizu J; Ishizu Y; Doizaki M; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Urano F; Yoshioka K; Toyoda H; Kumada T; Goto H
    Liver Int; 2010 Apr; 30(4):527-37. PubMed ID: 19523048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients.
    Beste LA; Green PK; Ioannou GN
    Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):123-9. PubMed ID: 25503739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr.
    Antonucci G; Longo MA; Angeletti C; Vairo F; Oliva A; Comandini UV; Tocci G; Boumis E; Noto P; Solmone MC; Capobianchi MR; Girardi E
    Am J Gastroenterol; 2007 Jul; 102(7):1383-91. PubMed ID: 17403072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans.
    Hu KQ; Currie SL; Shen H; Cheung RC; Ho SB; Bini EJ; McCracken JD; Morgan T; Bräu N; Schmidt WN; Jeffers L; Wright TL;
    Dig Dis Sci; 2007 Feb; 52(2):570-8. PubMed ID: 17226072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained virologic response and other potential genotype-specific roles of statins among patients with hepatitis C-related chronic liver diseases.
    Pandya P; Rzouq F; Oni O
    Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):555-65. PubMed ID: 25835493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
    Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
    Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial.
    Groessl EJ; Sklar M; Cheung RC; Bräu N; Ho SB
    Contemp Clin Trials; 2013 Jul; 35(2):97-107. PubMed ID: 23669414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis C in elderly patients.
    Horsmans Y
    Expert Opin Pharmacother; 2010 Mar; 11(4):571-7. PubMed ID: 20163268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of age on viral kinetics of peginterferon alfa-2a/ribavirin in chronic hepatitis C: final analysis from the PROPHESYS cohort.
    Aronsohn A; Ancuta I; Caruntu F; Coppola C; Delic D; Digiacomo A; Dusheiko GM; Lengyel G; Marcellin P; Orlandini A; Pruthi J; Silva GF; Tallarico L; Schmitz M; Tatsch F; Korner E; Cheinquer H
    J Viral Hepat; 2014 May; 21(5):377-80. PubMed ID: 24131506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C.
    Rowan PJ; Tabasi S; Abdul-Latif M; Kunik ME; El-Serag HB
    J Clin Gastroenterol; 2004 Jul; 38(6):530-4. PubMed ID: 15220690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C.
    Hu CC; Lin CL; Kuo YL; Chien CH; Chen SW; Yen CL; Lin CY; Chien RN
    Aliment Pharmacol Ther; 2013 Jan; 37(1):81-90. PubMed ID: 23121150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.
    Backus LI; Boothroyd DB; Phillips BR; Belperio P; Halloran J; Mole LA
    Clin Gastroenterol Hepatol; 2011 Jun; 9(6):509-516.e1. PubMed ID: 21397729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of prognostic factors for Peg Interferon alfa-2b plus ribavirin treatment on HCV infected patients in Pakistan.
    Aziz H; Gil ML; Waheed Y; Adeeb U; Raza A; Bilal I; Athar MA
    Infect Genet Evol; 2011 Apr; 11(3):640-5. PubMed ID: 21316487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C.
    Huang CF; Yang JF; Dai CY; Huang JF; Hou NJ; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Chuang WL; Yu ML
    J Infect Dis; 2010 Mar; 201(5):751-9. PubMed ID: 20102281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained virologic response among Latino veterans; does it represent the cure of chronic hepatitis C infection?
    De Jesús J; Nieves-Santiago P; Rodríguez-Pérez F; Toro DH
    P R Health Sci J; 2010 Dec; 29(4):397-401. PubMed ID: 21261181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C.
    Tseng CW; Chang TT; Tzeng SJ; Hsieh YH; Hung TH; Huang HT; Wu SF; Tseng KC
    Clin Interv Aging; 2016; 11():327-34. PubMed ID: 27051280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.